← Leaderboards
William Rodman Shankle
Medical Care Corporation
$1,907,582
Attributed
$1,907,582
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $940.2K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$1,907,582 · 2
By mechanism
R44$1,452,241 · 1
R43$455,341 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCognitionMedicalPerformance TestsS DiseaseFutureNeuroinformaticsNeuroimagingCognitiveSuccessEpidemicCaringCompetenceEnrollmentData SetDrug DevelopmentMemoryClinicImpaired CognitionExpectationLiteratureCare CostsEarly InterventionCognitive Process
Grant awards (5)
Validating Digital Cognitive Biomarkers to Advance Alzheimer's Drug Development$455,341
R43 · FY2021 · AG · contact PI
Predicting Impending Cognitive Decline in Cognitively Normal Individuals$304,325
R44 · FY2021 · AG · contact PI
Predicting Impending Cognitive Decline in Cognitively Normal Individuals$180,552
R44 · FY2021 · AG · contact PI
Predicting Impending Cognitive Decline in Cognitively Normal Individuals$837,630
R44 · FY2020 · AG · contact PI
Predicting Impending Cognitive Decline in Cognitively Normal Individuals$129,734
R44 · FY2019 · AG · contact PI